WealthTrust Axiom’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.79M | Sell |
|
|||||
2025
Q1 | $2.85M | Buy |
|
|||||
2024
Q4 | $2.31M | Buy |
|
|||||
2024
Q3 | $2.56M | Sell |
|
|||||
2024
Q2 | $2.42M | Sell |
|
|||||
2024
Q1 | $2.71M | Buy |
|
|||||
2023
Q4 | $2.24M | Buy |
|
|||||
2023
Q3 | $1.99M | Sell |
|
|||||
2023
Q2 | $2.07M | Buy |
|
|||||
2023
Q1 | $2.07M | Buy |
|
|||||
2022
Q4 | $1.65M | Buy |
|
|||||
2022
Q3 | $1.25M | Buy |
|
|||||
2022
Q2 | $2.29M | Sell |
|
|||||
2022
Q1 | $2.3M | Sell |
|
|||||
2021
Q4 | $2.33M | Sell |
|
|||||
2021
Q3 | $2.19M | Sell |
|
|||||
2021
Q2 | $2.34M | Buy |
|
|||||
2021
Q1 | $1.98M | Sell |
|
|||||
2020
Q4 | $2.05M | Buy |
|
|||||
2020
Q3 | $1.56M | Buy |
|
|||||
2020
Q2 | $1.07M | Sell |
|
|||||
2020
Q1 | $1.04M | Buy |
|
|||||
2019
Q4 | $1.28M | Buy |
|
|||||
2019
Q3 | $765K | Buy |
|
|||||
2019
Q2 | $518K | Sell |
|
|||||
2019
Q1 | $574K | Hold |
|
|||||
2018
Q4 | $525K | Hold |
|
|||||
2018
Q3 | $552K | Buy |
|
|||||
2018
Q2 | $429K | Buy |
|
|||||
2018
Q1 | $412K | Sell |
|
|||||
2017
Q4 | $456K | Buy |
|
|||||
2017
Q3 | $505K | Hold |
|
|||||
2017
Q2 | $536K | Buy |
|
|||||
2017
Q1 | $513K | Buy |
|
|||||
2016
Q4 | $413K | Buy |
|
|||||
2016
Q3 | $463K | Buy |
|
|||||
2016
Q2 | $465K | Buy |
|
|||||
2016
Q1 | $434K | Sell |
|
|||||
2015
Q4 | $459K | Buy |
|
|||||
2015
Q3 | $427K | Buy |
|
|||||
2015
Q2 | $463K | Sell |
|
|||||
2015
Q1 | $607K | Buy |
|
|||||
2014
Q4 | $539K | Buy |
|
|||||
2014
Q3 | $522K | Buy |
|
|||||
2014
Q2 | $607K | Sell |
|
|||||
2014
Q1 | $612K | Buy |
|
|||||
2013
Q4 | $595K | Buy |
|
|||||
2013
Q3 | $543K | Hold |
|
|||||
2013
Q2 | $541K | Buy |
|